PRTA Q1 2017 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$259,000-2.3% YoY

Gross Profit

-$25M-9822.0% margin

Operating Income

-$36M-14004.2% margin

Net Income

-$35M-13661.8% margin

EPS (Diluted)

$-0.99

QoQ Revenue Growth

+51.5%

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$40M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$582M

Total Liabilities

$86M

Stockholders' Equity

$496M

Cash & Equivalents

$507M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$259,000	$265,000	-2.3%
Gross Profit	-$25M	-$20M	-25.8%
Operating Income	-$36M	-$27M	-32.3%
Net Income	-$35M	-$28M	-28.6%